KE3340A - Process for preparing propanol derivatives - Google Patents

Process for preparing propanol derivatives

Info

Publication number
KE3340A
KE3340A KE3340A KE334083A KE3340A KE 3340 A KE3340 A KE 3340A KE 3340 A KE3340 A KE 3340A KE 334083 A KE334083 A KE 334083A KE 3340 A KE3340 A KE 3340A
Authority
KE
Kenya
Prior art keywords
propanol derivatives
preparing
preparing propanol
derivatives
propanol
Prior art date
Application number
KE3340A
Other languages
English (en)
Inventor
Hajos Andor
Fekete Marton
Kurti Marianna
Lang Tibor
Toldy Lajos
Borvendeg Janos
Nagy Laslo
Elek Sandor
Polgari Istvan
Elekes Istvan
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of KE3340A publication Critical patent/KE3340A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KE3340A 1976-03-02 1983-10-24 Process for preparing propanol derivatives KE3340A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76GO00001331A HU172137B (hu) 1976-03-02 1976-03-02 Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Publications (1)

Publication Number Publication Date
KE3340A true KE3340A (en) 1983-11-25

Family

ID=10996805

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3340A KE3340A (en) 1976-03-02 1983-10-24 Process for preparing propanol derivatives

Country Status (25)

Country Link
US (1) US4310549A (fr)
JP (1) JPS5923299B2 (fr)
AT (1) AT348507B (fr)
AU (1) AU508766B2 (fr)
BE (1) BE851938A (fr)
CA (1) CA1091254A (fr)
CH (1) CH627732A5 (fr)
CS (1) CS190340B2 (fr)
DD (1) DD128610A5 (fr)
DE (1) DE2709109C3 (fr)
DK (1) DK143554C (fr)
FI (1) FI65231C (fr)
FR (1) FR2342956A1 (fr)
GB (1) GB1573191A (fr)
HU (1) HU172137B (fr)
IL (1) IL51574A (fr)
IN (1) IN144243B (fr)
KE (1) KE3340A (fr)
MY (1) MY8500104A (fr)
NL (1) NL7702170A (fr)
NO (1) NO141989C (fr)
PL (1) PL103734B1 (fr)
SE (1) SE440647B (fr)
SU (1) SU648080A3 (fr)
YU (1) YU40813B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA009646B1 (ru) * 2003-05-30 2008-02-28 Рэнбакси Лабораториз Лтд. Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569692A5 (fr) 1971-03-17 1975-11-28 Richter Gedeon Vegyeszet
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives

Also Published As

Publication number Publication date
FI65231B (fi) 1983-12-30
AU2279577A (en) 1978-09-07
DK143554C (da) 1982-03-08
AT348507B (de) 1979-02-26
NO770688L (no) 1977-09-05
DD128610A5 (de) 1977-11-30
DE2709109B2 (de) 1980-01-17
CS190340B2 (en) 1979-05-31
DK143554B (da) 1981-09-07
IL51574A (en) 1980-01-31
AU508766B2 (en) 1980-04-03
NO141989B (no) 1980-03-03
SU648080A3 (ru) 1979-02-15
MY8500104A (en) 1985-12-31
SE440647B (sv) 1985-08-12
DE2709109C3 (de) 1980-09-18
HU172137B (hu) 1978-06-28
FI770651A (fr) 1977-09-03
JPS5923299B2 (ja) 1984-06-01
US4310549A (en) 1982-01-12
NO141989C (no) 1980-06-11
YU54977A (en) 1982-10-31
DK88577A (da) 1977-09-03
YU40813B (en) 1986-06-30
FR2342956A1 (fr) 1977-09-30
ATA134177A (de) 1978-07-15
CH627732A5 (de) 1982-01-29
CA1091254A (fr) 1980-12-09
DE2709109A1 (de) 1977-09-15
FI65231C (fi) 1984-04-10
SE7702251L (sv) 1977-09-03
GB1573191A (en) 1980-08-20
PL103734B1 (pl) 1979-07-31
JPS52122328A (en) 1977-10-14
IN144243B (fr) 1978-04-15
BE851938A (fr) 1977-09-01
NL7702170A (nl) 1977-09-06
FR2342956B1 (fr) 1982-11-26
IL51574A0 (en) 1977-05-31

Similar Documents

Publication Publication Date Title
CS194814B2 (en) Process for preparing methacroleine
HU172711B (hu) Sposob poluchenija proizvodnykh piperidil-indola
PT66713B (en) Process for preparing 4-hydroxyphenylalkanolamine derivatives
HU178040B (en) Process for preparing 8-aza-prostaglandin derivatives
HU175055B (hu) Sposob poluchenija novykh zameshchjonnykh proizvodnykh 2-fenil-amino-imidazol-2-ina
HU173606B (hu) Sposob poluchenija proizvodnykh benzo-sul'fo-karbamida
HU178806B (en) Process for preparing benzyl-cyano-acetal derivatives
YU13577A (en) Process for preparing new quinazoline-di-n-oxide derivatives
CS189032B2 (en) Process for preparing n-alkyldiphenylamines
HU173939B (hu) Sposob poluchenija zakisi azota
HU174532B (hu) Sposob poluchenija p-izobutil-gidratropata gvajakola
HU174982B (hu) Sposob poluchenija proizvodnykh 17al'fa-gidroksi-pregnan-20-ona
HU171269B (hu) Sposob poluchenija novykh proizvodnykh trifenil-alkenov
HU179449B (en) Process for preparing substituted 2-vinyl-chromon derivatives
MY8500104A (en) Process for preparing propanol derivatives
HU172999B (hu) Sposob poluchenija 2-okso-pirrolidinil-n-alkil-amidov
JPS5323948A (en) Novel process for preparing streptamine derivatives
JPS52148100A (en) Process for preparing novel liphamycine derivatives
GB1545647A (en) Process for preparing beta-methyldigoxin
HU177936B (en) Process for preparing 1-dialkylamino-2-alkin-4-ol derivatives
HU176954B (hu) Sposob poluchenija proizvodnykh cis-geksagidro-dibenzopiranona
YU70177A (en) Process for preparing sandwicin derivatives
HU183632B (en) Process for preparing 4-thioxy-2-azetidinone derivatives
CS193538B2 (en) Process for preparing derivatives n-aminoalkyl-n-phenyl--2-aminoindane
HU178092B (en) Process for preparing 7-alkoxy-cefem or 6-alkoxy-penam derivatives